Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Reproductive - Pharmacology > Treatment of Breast and Endometrial Cancer > Flashcards

Treatment of Breast and Endometrial Cancer Flashcards

(51 cards)

Start Studying
1
Q

What is the only way to treat Triple negative breast cancer?
- what is the best method of treating this cancer?

A

Triple Negative Breast Cancers: ONLY treated with CONVENTIONAL agents excision of the cancer and surrounding nodes is your best option

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A woman presents at age 45 with dilated cardiomyopathy after treatment for breast cancer at age 25, what drug likely caused this side effect?

A

***cumulative dose effect of doxorubicin may present as a women who develops heart failure at a young age following breast cancer treatment***

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the standand Adjuvant therapies for breast cancer?
- what classes of anti-cancer drugs are these?

A

Cyclophosphamide (Alkylating agent) + Doxorubicin (Chelating, Topo inbitor = anthracyclin) +/- Taxane or 5-FU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why are drugs that block ER not more effective at treating estrogen sensistive breast cancer?

A

Estrogen mediates effects in the cell genomically through the ER, but also can bind to cell surface receptors to have more immediate effects.

**this is why we need to use mTOR inhibitors like Everolimus**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If someone with a BRCA mutation refuses to undergo a prophylactic mastectomy, but is willing to take drugs, then what drugs can you give them?

A

Chemoprevention of breast cancer can be done with Tamoxifen or Raloxifene (SERMs)

**This is hardly ever used for BRCA 1 mutations because these cancers are most often ER-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are aromatase inhibitors not used in younger women?

A

Peripheral Conversion of Androgen to Estrone in PREmenopausal women is insignificant compared to the estrogen produced by their ovaries
**Also Aromastase inhibitors are teratogens***

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is the progesterone receptor even evaluated in breast cancers?

A

*While no drugs target the progesterone receptor directly, presence of the progesterone receptor alone diverts estrogen effects from being proliferative and more towards differentiation and apoptosis*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T or F: Anti-estrogen therapy is very effective at CURING cancer.

A

False, average remission time for Anti-Estrogen therapy is 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of the BRCA genes and where in the cell cycle are they most important?

A
  • *Gene Mutations in Breast Cancer:**
  • BRCA1/2: important for homologous recombination (DNA repair) in the S and G2 phases of the cell cycle. Loss of these genes allow for progression of the cell cycle in the presence of aberrant DNA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drugs act as aromatase inhibitors?

A

Anastrozole, Letrozole, Exemestane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the only groups that are approved to take aromatase inhibitors in the treatment of breast cancer?
**name these drugs**

A

ONLY used in postmenopausal women. This is because peripheral fat stores are the primary location of aromatase, which converts circulating androgens into estrogen, which feed the cancer.

Anastrozole, Letrozole, Exemestane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aromastase Inhibitors

  • ADMINISTRATION
  • MOA
  • Name them
A

Anastrozole, Letrozole, Exemestane
ADMINISTRATION
Daily ORAL

MOA
Inhibition of the Aromatase enzyme in fat tissue (of post-menopausal women) to prevent androgen conversion into estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aromase Inhibitors

  • Adverse Effects (compare these to tamoxifen)
  • Indication (type of breast cancer)
  • NAME THEM
A

Anastrozole, Letrozole, Exemestane

ADVERSE EFFECTS
Hot flashes, Hair thinning, Arthralgia, Diarrhea
FEWER gyn symptoms than Tamoxifen (b/c there is no proestrogeninic effect of these drugs)

*****TERATOGEN****not an issue in post-menopausal women

INDICATION
ER+ breast cancer in post-menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aromatase Inhibitors

  • Contraindications
  • what would you do if a cancer became resistant to Letrozole?
  • Name them
A

Anastrozole, Letrozole, Exemestane

CONTRAINDICATION
Pregnancy – not an issue since they’re only indicated for post-menopausal women

***Exemestane – IMPORTANTLY has a steroidal structure while the other 2 do not so cross resistance between steroidal (Exemestane) and non-steriodal (Anastrozole, Letrozole) agents is not a problem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What SERMS are used in the treatment of breast cancer?

A

Raloxifene/Tamoxifen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Are SERDs and SERMs typically used in pre or post menopausal women?

A

Can be used in pre or postmenopausal women, but typically only used in postmenopausal women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In tissues where SERMs act to deactivate the cells, what do they do upon entering the cell?
- name the SERMs

A

The ability of SERMs to have activating properties in some tissues and deactivating properties in other tissues depends on the proteins that it recruits when it gets there. In tissue that get deactivated the ER+Tamoxifen complex activates a HDAC (histone deacetylase) that acts to repress mRNA production.

SERMs = Raloxifene/Tamoxifen/Toremifene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Raloxifene/Tamoxifen

  • Administration
  • MOA
A

Raloxifene/Tamoxifen
ADMINISTRATION
PO

MOA
SERMs = Selective Agonists of ER and antagonists of others and thus have effects of decreasing hormone stimulation of breast cancer and increasingbone density and positive effects on cholesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Raloxifene/Tamoxifen

  • adverse effects (how do these differ between the two drugs?)
  • BBWs
A

Raloxifene/Tamoxifen

ADVERSE EFFECTS
**Teratogens
** Retinal Degeneration at High Doses

  • ***************BBWs********************
  • *Tamoxifen only:** Endometrial Hypertrophy/Polyps, Vaginal Bleeding, Endometrial Cancer

BOTH:Thromboembolism, Stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Raloxifene/Tamoxifen
Indication
Contraindication

A

Raloxifene/Tamoxifen

INDICATION
Post-menopausal women with ER + breast cancer

CONTRAINDICATION
Pregnancy, but this isn’t an issue in post-menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Toremifene has fewer BBWs than Raloxifene and Tamoxifen, but what BBW does it has that is different than these two drugs?

Study These Flashcards
A

Toremifene - prolongs the QT interval
**So avoid this drug with any pre-existing heart conditions**

22
Q
  • *Toremifine**
  • Administration
  • MOA (why might these people experience less activity with drug compared to others in its class?)
Study These Flashcards
A

Toremifene
ADMINISTRATION
PO DAILY, CYP3A4 metabolized (watch out for grapefruit juice etc.)

MOA
SERMs = Selective Agonists of ER and antagonists of others and thus have some effects of increased bone density and positive effects on cholesterol.
Derivative of Tamoxifen
**Slow CYP2D6 metabolizers may experience less drug activity due to less production of ENOXIFEN – an extremely active metabolite of tamoxifen.

23
Q

Toremifene
- Adverse Effects

Study These Flashcards
A

ADVERSE EFFECTS
BBW specific to Toremifene: PROLONGS QT interval/PRO-ARRYTHMOGENIC

Similar Side effects but not BBWs as tamoxifen (see below)

Teratogen

Retinal Degeneration at High Doses
Tamoxifen: Endometrial Hypertrophy, Vaginal Bleeding, Endometrial Cancer, Thromboembolism, Stroke

24
Q

Toremifene

  • Indication
  • Contraindication
Study These Flashcards
A

INDICATION
Postmenopausal women with ER+ Breast cancer

CONTRAINDICATION
Pregnancy, but this isn’t an issue in post-menopausal women

25
Name the SERMs. - how are they different from the SERDs? - Name the SERD.
SERMs: - **Tamoxifene, Raloxifene, and Toremifene** * *SERDs (Fulvestrant) - are PURE antagonists with NO ESTROGENIC EFFECTS**
26
Fulvestrant - Administration - MOA
**Fulvestrant** Administration **Monthly IM injections** MOA **SERD not SERM** so = **PURE ANTAGONIST** with **NO estrogenic effects,** **bulky adduct prevents ER receptor dimerization**
27
* *Fulvestrant** - Adverse Effects - Indication
Adverse Effects - \*\*Make sense on the basis of the MOA\*\* **Mostly perimenopausal symptoms of Nausea, asthenia, pain, vasodilation (HOT FLASHES), and headache**
28
* *Fulvestrant** - Indication - Contraindication
_Indication_ ER+ Breast Cancer in Post-menopausal women following failed anti-estrogen therapy _Contraindication_ ER negative Cancers
29
What drugs act on the HER2 signaling pathway? - what are the different points at which they work? (there are 4 drugs)
**Trastuzumab** - bind **Juxtaglomerular region of HER2** **Pertuzumab** - binds binds the **extracellular dimerization domain of HER2** **Lapatinib** - binds the **ATP binding site on the HER2 TKI** **Everlolimus** - blocks **mTOR** (downstream from receptor)
30
Her-2/Neu Antibodies (2 of them) - Administration - MOA
Pertuzumab/Trastuzumab ADMINISTRATION IV administration with TAXANES MOA * *Pertuzumab** - Binds to HER2 receptor to block the extracellular **dimerization domain** * *Trastuzumab** - binds to the **Juxtagolmerular region** of the extracellular HER2 domain
31
HER-2/neu antibodies - name them. - Adverse Effects (how do these differ between the two drugs?)
**Pertuzumab/Trastuzumab** _ADVERSE EFFECTS_ INFUSION RXNS are especially prominent with Trastuzumab BOTH: *HEART FAILURE*, Respiratory distress, GI upset, Blood Dyscrasia, Hepatotoxicit and pneumonia BBW (traztuzumab) **PREGNANCY, HEART/HEPATIC TOXICITY, RESPIRATORY ISSUES (Traztuzumab)**
32
What HER2-neu antibody do you not have to give with a Taxane? - explain
Ado-Trastuzumab Emtasine ADMINISTRATION IV administration MOA Binds to **HER2 receptor causing internalization like Trastuzumab**, but it has an **anti-microtubule agent attached to it that acts upon entering the cell**
33
Indication for HER-2 antibody drugs? - contraindication?
_INDICATION_ **HER-2 positive breast cancer** _CONTRAINDICATION_ **CHF, Liver Disease, Respiratory Disease (epecially trastuzumab)**
34
What HER2-TKIs are used in the Tx of HER2 positive breast cancer? - administaration - MOA
**Lapatinib** _ADMINISTRATION_ **Oral** _MOA_ Inhibitor of HER1 and HER2 by binding to the intracellular ErbB1 and 2 domains to **PREVENT ATP binding (like all TKIs)**
35
Lapatinib (HER2 - TKI blocker) - Adverse Effects
_ADVERSE EFFECTS_ Common: **ELEVATED LFT**s, *Hand-foot syndrome*, rash, GI toxicity, Anemia Serious: **INTERSTITIAL LUNG Dz./pneumonitis; QT prolongation**
36
Lapatinib - Indication - Adverse Effects
_INDICATION_ HER2 positive Breast Cancer _CONTRAINDICATION_ BBW: **Liver Disease** or Dysfunction =\> *toxicity following normal dosing regimen*
37
T or F: GnRH agonists and antagonists are only used for breast cancer treatment in pre-menopausal women
True, this is because the HPO axis is firing (producing lots of FSH), but ovarian estrogen is not significant in postmenopausal women.
38
GnRH agonist used in breast cancer? - Administration - MOA
**Goserelin** _ADMINISTRATION_ SC injection _MOA_ **Persistent Agonism** of the **GnRH receptor** leads to increased FSH and LH levels followed by **DOWNREGULATION of the receptor**
39
Gosrelelin (GnRH agonist) - Adverse Effects
**Goserelin** _ADVERSE EFFECTS_ **Hypo-estrogeneic state** = *Decreased Bone Density* (*perpetuated by EtOH and tobacco use*; *FHx of Osteoporosis*); _Amenorrhea, Hot Flashes, Decreased Libido/vaginal dryness, emotional lability, sweating_
40
What drug used to treat **ER positive, HER2 negative** breast cancer increases the patient's risk of **neoplasia and lymphoma**?
EVEROLIMUS
41
Everolimus Administration MOA
**Everolimus** _ADMINISTRATION_ ORAL? _MOA_ Binds FKBP-12 that forms a **3 way complex with mTOR** that prevents it from performing its usual functions of promoting synthesis of proteins involved in Angiogenesis, Cell metabolism, and Proliferation.
42
Everolimus - Adverse Effects
**Everolimus** _ADVERSE EFFECTS_ **Non-infectious Pneumonitis, Blood dyscrasias, Hyperglycemia, Hyperlipidemia/triglyceridemia, ELEVATED CREATININE** **BBW: RISK OF OPPORTUNISTIC INFECTIONS, NEOPLASIA, LYMPHOMA, SCC**
43
Everolimus - Indication
INDICATION Used with exemestane in advanced **ER+, HER-2 negative tumors**
44
What mAb is used to treat the symptoms that are produced when cancer metastasizes to bone? - Administration - MOA
**Denosumab** _ADMINISTRATION_ Parental _MOA_ mAb against RANKL preventing osteoclast stimulation
45
Denosumab - Adverse Effects - Indication
_ADVERSE EFFECTS_ Weakened immune system _INDICATION_ * *Metastasis to bone** – *males and females with hormone sensitive cancers are at an especially increased risk because they are probably blocking estrogen production needed to maintain bone* * *Especially useful in tumors secreting PTHrP** \*\*No contraindications mentioned\*\*
46
What progesterone analogs are used in the treatment of Endometrial Cancer? - which might be effective in breast cancer too? why?
**medroxyprogesterone and Megostrol Megostrol may be useful in treating breast cancer by exerting a cytotoxic effect on BC cells by interfering with the availability, stability, and turnover of estrogen and the interacting with estrogen and progesterone receptor complexes**
47
Medroxyprogesterone - Administration - MOA
**Medroxyprogesterone** _ADMINISTRATION_ SC? Or IM? – as a depot _MOA_ **Binds to PROGESTIN receptors to block GnRH release** Often used as a contraceptive
48
Medroxyprogesterone Adverse Effects Indication
**Medroxyprogesterone** _ADVERSE EFFECTS_ Amenorrhea, edema, anorexia, weakness, WEIGHT GAIN INDICATION Endometrial Carcinoma Cachexia tx in AIDS and Cancer patients
49
Megestrol - Administration - MOA
ADMINISTRATION Oral MOA **Synthetic progestin used to block LH release from the pituitary and enhance estrogen degradation**
50
Megestrol - Adverse Effects
**Megestrol** _ADVERSE EFFECTS_ **Tumor Flare and Hypercalcemia in BC pts with bony metastasis Thrombophlebitis, Thrombo- or pulmonary embolism**
51
Megestrol - Indication
INDICATION **Endometrial Carcinoma**. *Occasionally breast Carcinoma*

Reproductive - Pharmacology (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions